Company Filing History:
Years Active: 2016
Title: **Gregor Schürmann: Innovator in Antibody Technology**
Introduction
Gregor Schürmann is an accomplished inventor based in Hannover, Germany. He has made significant contributions to the field of biotechnology, focusing on antibody redirection. With a single patent to his name, Schürmann's work exemplifies the combination of innovation and scientific advancement.
Latest Patents
Gregor Schürmann holds a patent for "High Affinity Adaptor Molecules for Redirecting Antibody Specificity." This patent describes methods for identifying high-affinity adaptor molecules that can bind to both a circulating antibody and a target molecule. The innovative aspect of his invention lies in its ability to redirect the specificity of the circulating antibody to the target molecule, enhancing therapeutic options in antibody-based treatments.
Career Highlights
Currently, Gregor Schürmann is employed at Tripep AB, where he continues to delve into the complexities of antibody technology. His expertise and dedication to his research have positioned him as a vital figure in his field.
Collaborations
Gregor Schürmann collaborates with notable colleagues, including Albert Collinson and Peter Wagner. Their collective expertise fosters an environment of creativity and innovation, enabling them to push the boundaries of biotechnological advancements.
Conclusion
Gregor Schürmann's journey as an inventor showcases the impact of innovative thinking in biotechnology. His pioneering work in developing high-affinity adaptor molecules not only highlights his individual achievements but also represents the collaborative spirit of his workplace. As he continues his career, Schürmann is set to leave an indelible mark on the field of antibody technology.